Publicaciones en colaboración con investigadores/as de Hospital Universitario de Salamanca (48)

2023

  1. Brentuximab vedotin in the treatment of cutaneous T-cell lymphomas: Data from the Spanish Primary Cutaneous Lymphoma Registry

    Journal of the European Academy of Dermatology and Venereology, Vol. 37, Núm. 1, pp. 57-64

  2. Cost of Treating Cutaneous T-Cell Lymphoma in Spain: Analysis of MICADOS Study Data by Disease Stage

    Actas Dermo-Sifiliograficas

  3. TMeB score may improve risk stratification of high-risk cutaneous squamous cell carcinoma and guide management of patients: A pilot study

    Journal of the European Academy of Dermatology and Venereology

2022

  1. A Novel Approach for the Shape Characterisation of Non-Melanoma Skin Lesions Using Elliptic Fourier Analyses and Clinical Images

    Journal of Clinical Medicine, Vol. 11, Núm. 15

  2. Deep Convolutional Neural Support Vector Machines for the Classification of Basal Cell Carcinoma Hyperspectral Signatures

    Journal of Clinical Medicine, Vol. 11, Núm. 9

  3. Graft versus host disease-related eosinophilic fasciitis: cohort description and literature review

    Advances in Rheumatology, Vol. 62, Núm. 1

  4. Outcome of cutaneous squamous cell carcinoma with microscopic residual disease after surgery and usefulness of postoperative radiotherapy: a retrospective cohort study

    Journal of the European Academy of Dermatology and Venereology, Vol. 36, Núm. 6, pp. 846-854

2021

  1. Definition of prognostic subgroups in the T3 stage of the eighth edition of the American Joint Committee on Cancer staging system for cutaneous squamous cell carcinoma: Tentative T3 stage subclassification

    Journal of the American Academy of Dermatology, Vol. 85, Núm. 5, pp. 1168-1177

  2. Double Wolf's isotopic response in a patient with B-cell chronic lymphocytic leukemia

    Piel, Vol. 36, Núm. 7, pp. 455-457

  3. Hyperspectral imaging and robust statistics in non-melanoma skin cancer analysis

    Biomedical Optics Express, Vol. 12, Núm. 8, pp. 5107-5127

  4. Overcoming resistance to immunotherapy in advanced cutaneous squamous cell carcinoma

    Cancers, Vol. 13, Núm. 20

  5. Patients with primary cutaneous lymphoma are at risk for severe COVID-19. Data from the Spanish Primary Cutaneous Lymphoma Registry

    Journal of the European Academy of Dermatology and Venereology

  6. Performance of Salamanca refinement of the T3-AJCC8 versus the Brigham and Women's Hospital and Tübingen alternative staging systems for high-risk cutaneous squamous cell carcinoma

    Journal of the American Academy of Dermatology, Vol. 84, Núm. 4, pp. 938-945

  7. Spectrum of Clinicopathologic Findings in COVID-19-induced Skin Lesions: Demonstration of Direct Viral Infection of the Endothelial Cells

    American Journal of Surgical Pathology, Vol. 45, Núm. 3, pp. 293-303

2020

  1. "Book Flap" Approach for Temporal Artery Biopsy

    Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], Vol. 46, Núm. 10, pp. 1361-1363

  2. Postoperative radiotherapy provides better local control and long-term outcome in selective cases of cutaneous squamous cell carcinoma with perineural invasion

    Journal of the European Academy of Dermatology and Venereology, Vol. 34, Núm. 5, pp. 1080-1091

2019

  1. Bullous pemphigoid and DPP4 inhibitors

    Medicina Clinica, Vol. 153, Núm. 9, pp. 368-371

  2. Comparing the eighth and the seventh editions of the American Joint Committee on Cancer staging system and the Brigham and Women's Hospital alternative staging system for cutaneous squamous cell carcinoma: Implications for clinical practice

    Journal of the American Academy of Dermatology, Vol. 80, Núm. 1, pp. 106-113.e2

  3. Cutaneous collagenous vasculopathy: Papular form

    Dermatology Online Journal, Vol. 25, Núm. 8

2018

  1. Aggressive primary cutaneous CD30+ lymphoproliferative disorder in an organ transplant recipient in sustained complete remission with brentuximab vedotin

    International Journal of Dermatology